INTRODUCTION
Oral squamous cell carcinoma (OSCC) is the most common malignant tumor of the oral cavity worldwide and consistently increasing in developing countries. OSCC is characterized by a high degree of local invasiveness and highly metastasize to the cervical lymph nodes.
1,2 Despite recent improved clinical surgery and development of new anticancer drugs, OSCC has high mortality rate in patients with distant metastases. Therefore, the early diagnosis and standard treatments is extremely important to inhibit the onset and progression of oral carcinomas. 3 Furthermore, alternative cancer therapy has been demanded for control OSCC and phytochemicals has been suggested as the major source for anticancer agents against a various malignant tumors.
Fig. 1. Chemical structure of BS-IV.
Apoptosis, the programmed cell death, is critical for cellular homeostasis and is also one of the important mechanisms for the treatment of various cancers. 4 The apoptotic process is induced by both death receptor (extrinsic) pathway and mitochondrial (intrinsic) pathway.
The death receptor-mediated pathway involves the Fas, was also shown to evidence a remarkable hepatoprotective effect, antiviral activity and cytotoxicity against a panel of seven different cancer cell lines. 8 In the previous study, we reported that BS-IV induces cell cycle arrest and apoptosis in human papillomaviruses infection-immortalized human oral keratinocytes. 9 The present study aimed to estimate the chemopreventive potential of BS-IV against the highly invasive human OSCC cell line. We examined whether BS-IV could induce cell cycle arrest and apoptosis in YD-10B cells, and further explored the mechanism underlying its activity.
MATERIALS AND METHODS
Materials

BS-IV was generously provided by Professor Hee-Juhn
Park in Sangji University, 6 dissolved in dimethyl sulfoxide 
RESULTS
BS-IV inhibits the viability of YD-10B OSCC cells
When YD-10B human OSCC cells were cultured in serum-free medium with various concentrations of BS-IV, cell viability was dose-and time-dependently decreased (Data not shown). Its half maximal inhibitory concentration (IC50) values were 22.5 μM for 24 h treatment and 9.6 μM for 48 h treatment.
BS-IV induces cell cycle arrest at G2/M phase in YD-10B OSCC cells
We determined whether BS-IV could block cell cycle progression of YD-10B cells by flow cytometric analysis.
When YD-10B cells were treated with 10 μM BS-IV for 24 h, the percentage of YD-10B cells in the G2/M and S phase was slightly increased, but that in G0/G1 phase was decreased (Fig. 2) . The cell cycle machinery is regulated by cyclins and Cdks, and the activities of the different cyclin-Cdk complexes modulate to control specific phases in the cell cycle. G2 to M phase progression is mainly controlled by the Cdc2-cyclin B1 complex, and Cdc25C
phosphatase results in activation of Cdc2 by dephosphorylation. 11 In addition, the phosphorylation of Chk2 activates the G2 checkpoint. 12, 13 Western blot analysis indicated that the levels of cyclin B1 and Cdk2 were significantly decreased and the level of the phosphorylated Chk2 was dose-dependently enhanced in BS-IV-treated YD-10B cells (Fig. 3A) . BS-IV treatment did not affect the levels of Cdc2 and Cdc25c. In addition, the increased p21 protein level (Fig. 3B ) and the reduced level of phospho- rylated Akt (Fig. 3C) , which can directly phosphorylate p21
and drop its level in nucleus, 14 were observed in YD-10B cells treated with BS-IV for 24 h.
BS-IV induces apoptosis in YD-10B OSCC cells
We further studied whether BS-IV could induce apoptosis in YD-10B cells. BS-IV treatment for 24 h induced morphological changes and apoptotic morphological changes were confirmed by DAPI staining (Fig. 4) . The expression of
Bax was increased and Bcl-2 level was reduced in BS-IV-treated cells (Fig. 5A) . Consequently, BS-IV treatment resulted in an increase in the Bax/Bcl-2 ratio, leading to the release of cytochrome c from mitochondria (Fig. 5B) .
Moreover, treatment with BS-IV elevated the level of active caspase-3 and induced the cleavage of PARP (Fig. 5B) .
Furthermore, BS-IV stimulation caused the increased expression of Fas and FasL (Fig. 5C ).
DISCUSSION
OSCC is particularly dangerous because of a high risk of producing secondary tumors and captures about 90% of overall oral cancers. BS-IV is an excellent candidate for a chemopreventive agent to block the progression of highly invasive OSCC. In addition, BS-IV has anti-inflammatory, anti-viral and anti-hepatotoxic activities as active compound of P. kamtschaticum traditionally used to treat various kinds of disorders such as colds, arthritis, and impotence. Thus, BS-IV and the extracts with it may serve as beneficial supplement for health promotion. Furthermore, the evaluation on bioavailability of BS-IV is determined.
